The clinical research of nystatin in prevention of invasive fungal infections in patients on mechanical ventilation in intensive care unit

Chinese Critical Care Medicine

Volumn 25, Issue 8, 2013, Pages 475-478

  Chen, Zhi ^a   Yang, Chun Li ^b   He, Hui Wei ^b   Zeng, Jun ^b  

^a People's Hospital of Jiangxi Province   (China)

^b NONE

Author keywords

Invasive fungal infections; Mechanical ventilation; Nystatin

Indexed keywords

NYSTATIN; PLACEBO; PROKINETIC AGENT;

ARTICLE; ARTIFICIAL VENTILATION; ASSESSMENT OF HUMANS; CANDIDA ALBICANS; CANDIDEMIA; CLINICAL RESEARCH; CONTROLLED STUDY; CORRECTED COLONIZATION INDEX; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DAY HOSPITAL; DRUG EFFECT; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; STOMACH TUBE; SYSTEMIC MYCOSIS; ADULT; AGED; CONTROLLED CLINICAL TRIAL; FEMALE; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MYCOSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CANDIDA ALBICANS; CANDIDEMIA; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MYCOSES; NYSTATIN; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL;

EID: 84928238333     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.2095-4352.2013.08.007     Document Type: Article

References (25)

1. Hassan I,Powell G, Sidhu M,et al. Excess mortality,length of stay and cost attributable to candidaemia. J Infect,2009,59:360-365.
2. Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care,2010,16:445 452.
3. Marr KA. Invasive Candida infections:the changing epidemiology. Oncology(Williston Park),2004,18:9 14.
4. Vardakas KZ,Michalopoulos A,Kiriakidou KG,et al.Candidaemia: incidence,risk factors,characteristics and outcomes in immunocompetent critically ill patients. Clin Microbiol Infect,2009,15: 289-292.
5. Orii KO,Iwao Y,Higuchi W,et al. Molecular characterization of methicillin resistant Staphylococcus aureus from a fatal case of necrotizing fasciitis in an extremely low birth weight infant. Clin Microbiol Infect,2010,16:289-292.
6. Voss A,Hollis RJ,Pfaller MA,et al. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol, 1994,32:975-980.
7. Nucci M,Anaissie E. Revisiting the source of candidemia: skin or gut?. Clin Infect Dis, 2001,33:1959-1967.
8. Hu R,Jiang X,Wu Y. Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies. Neoplasma,2013,60:315-321.
9. Giglio M,Caggiano G,Dalfino L,et al. Oral nystatin prophylaxis in surgical/trauma ICU patients :a randomised clinical trial. Crit Care, 2012,16:R57.
10. Caggiano G,Puntillo F,Coretti C,et al. Candida colonization index in patients admitted to an ICU. Int J Mol Sci,2011,12:7038-7047.
11. Tortorano AM,Caspani L,Rigoni A L,et al. Candidosis in the intensive care unit:a 20 year survey. J Hosp Infect,2004,57: 8-13.
12. Olaechea PM,Palomar M,León Gil C,et al. Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis, 2004,23:323-330.
13. Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: results of 28 month European Confederation of Medical Mycology (ECMM) hospital based surveillance study. Eur J Clin Microbiol Infect Dis,2004,23: 317-322.
14. Tortorano AM,Kibbler C,Peman J,et al. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents,2006,27: 359-366.
15. León C,Alvarez Lerma F, Ruiz Santana S,et al. Fungal colonization and/or infection in non neutropenic critically ill patients : results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis, 2009,28:233-242.
16. Leleu G, Aegerter P, Guidet B, et al. Systemic candidiasis in intensive care units:a multicenter,matched cohort study. J Crit Care, 2002,17:168-175.
17. Guo F, Yang Y,Kang Y,et al. Invasive candidiasis in intensive care units in China:a multicentre prospective observational study. J Antimicrob Chemother,2013,68:1660-1668.
18. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg, 1994,220:751-758.
19. Piarroux R,Grenouillet F,Balvay P,et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med, 2004,32:2443-2449.
20. Sypula WT,Kale Pradhan P B. Therapeutic dilemma of fluconazole prophylaxis in intensive care. Ann Pharmacother,2002,36:155-159.
21. Rex JH,Sobel JD. Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis,2001,32:1191-1200.
22. Pelz RK, Hendrix CW, Swoboda SM, et al. Double blind placebo controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg,2001,233:542-548.
23. Giuliano S, Ceccarelli G, Renzini V, et al. Candidemia in Neurosurgical Intensive Care Unit:preliminary analysis of the effect of topical Nystatin prophylaxis and adequate source control on patients with early tracheostomy intubation. Ann Ig,2013,25:57-64.
24. Schuster MG,Edwards JE Jr,Sobel JD,et al. Empirical fluconazole versus placebo for intensive care unit patients:a randomized trial. Ann Intern Med,2008,149:83-90.
25. Schelenz S. Management of candidiasis in the intensive care unit. J Antimicrob Chemother,2008,61 Suppl 1:i31-34.